News & Updates

Early remdesivir treatment lowers risk of COVID-19 progression
Early remdesivir treatment lowers risk of COVID-19 progression
19 Jan 2022 byJairia Dela Cruz

In the treatment of patients with COVID-19, administering remdesivir within 5 days of symptom onset appears to reduce the risk of progression to severe disease, as shown in a study.

Early remdesivir treatment lowers risk of COVID-19 progression
19 Jan 2022
Anxiety, depressive symptoms in JIA tied to pain, stress
Anxiety, depressive symptoms in JIA tied to pain, stress
19 Jan 2022

Moderate to severe symptoms of anxiety and depression have been reported in about one-fourth of children with juvenile idiopathic arthritis (JIA), according to a study. Such symptoms are associated with pain and stress, but not with other disease manifestations.

Anxiety, depressive symptoms in JIA tied to pain, stress
19 Jan 2022